法国医院衰弱风险评分的外部验证
该研究基于法国2017年743家医院急诊入院的75岁及以上患者(n=1,042,234)的医疗信息数据库进行回顾性分析,外部验证医院衰弱风险评分(HFRS)。结果显示高HFRS与30天住院死亡风险和住院超过10天的风险增加相关,但对30天再入院的预测能力较差。将评分限制在索引入院之前的数据会大幅降低HFRS的区分度。
要点
- HFRS可用于法国75岁及以上急诊入院患者30天住院死亡和住院超过10天风险的评估。
- HFRS对30天再入院的预测能力较差,aOR=1.00(0.98-1.02),c-statistic=0.600。
- 仅使用索引入院前的数据计算HFRS会大幅降低其区分度。
核心结论
- HFRS可在法国用于判断75岁及以上急诊入院患者30天住院死亡和住院超过10天的风险,但不适用于30天再入院。
研究设计与样本
- 回顾性分析法国医疗信息数据库,纳入743家医院2017年所有75岁及以上急诊入院患者(n=1,042,234)。
- HFRS根据索引住院及前2年住院数据计算,采用混合逻辑回归模型分析结局与HFRS评分的关联。
主要发现
- 模型校准优秀。
- 将评分限制在索引入院之前的数据会大幅降低HFRS的区分度。
临床怎么用
- 可利用常规收集的医院数据计算HFRS,识别75岁及以上急诊入院患者中30天住院死亡和住院超过10天的高风险人群。
- 不应将HFRS用于预测30天再入院风险。
- 计算HFRS时需包含索引住院及前2年住院数据,仅用索引入院前数据会降低区分度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Hospital Frailty Risk Score (HFRS) has made it possible internationally to identify subgroups of patients with characteristics of frailty from routinely collected hospital data. OBJECTIVE: To externally validate the HFRS in France. DESIGN: A retrospective analysis of the French medical information database. SETTING: 743 hospitals in Metropolitan France. SUBJECTS: All patients aged 75 years or older hospitalised as an emergency in 2017 (n = 1,042,234). METHODS: The HFRS was calculated for each patient based on the index stay and hospitalisations over the preceding 2 years. Main outcome measures were 30-day in-patient mortality, length of stay (LOS) >10 days and 30-day readmissions. Mixed logistic regression models were used to investigate the association between outcomes and HFRS score. RESULTS: Patients with high HFRS risk were associated with increased risk of mortality and prolonged LOS (adjusted odds ratio [aOR] = 1.38 [1.35-1.42] and 3.27 [3.22-3.32], c-statistics = 0.676 and 0.684, respectively), while it appeared less predictive of readmissions (aOR = 1.00 [0.98-1.02], c-statistic = 0.600). Model calibration was excellent. Restricting the score to data prior to index admission reduced discrimination of HFRS substantially. CONCLUSIONS: HFRS can be used in France to determine risks of 30-day in-patient mortality and prolonged LOS, but not 30-day readmissions. Trial registration: Reference ID on clinicaltrials.gov: ID: NCT03905629.
引用
- Gilbert T, Cordier Q, Polazzi S, et al. External validation of the Hospital Frailty Risk Score in France. Age Ageing. 2022. PMID: 34185827. doi:10.1093/ageing/afab126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。